BRPI0409521A - uso do pentapeptìdeo iiaek, do pentapeptìdeo ipavf e/ou do hexapeptìdeo ipavfk, produto alimentìcio e processo para a preparação de um produto alimentìcio - Google Patents

uso do pentapeptìdeo iiaek, do pentapeptìdeo ipavf e/ou do hexapeptìdeo ipavfk, produto alimentìcio e processo para a preparação de um produto alimentìcio

Info

Publication number
BRPI0409521A
BRPI0409521A BRPI0409521-9A BRPI0409521A BRPI0409521A BR PI0409521 A BRPI0409521 A BR PI0409521A BR PI0409521 A BRPI0409521 A BR PI0409521A BR PI0409521 A BRPI0409521 A BR PI0409521A
Authority
BR
Brazil
Prior art keywords
pentapeptide
food product
iiaek
ipavf
ipavfk
Prior art date
Application number
BRPI0409521-9A
Other languages
English (en)
Inventor
Johannes Gerardus Mari Janssen
Johannes Schalk
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of BRPI0409521A publication Critical patent/BRPI0409521A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4717—Plasma globulins, lactoglobulin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C21/00—Whey; Whey preparations
    • A23C21/02—Whey; Whey preparations containing, or treated with, microorganisms or enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"USO DO PENTAPEPTìDEO IIAEK, DO PENTAPEPTìDEO IPAVF E/OU DO HEXAPEPTìDEO IPAVFK, PRODUTO ALIMENTìCIO E PROCESSO PARA A PREPARAçãO DE UM PRODUTO ALIMENTìCIO". A presente invenção refere-se ao uso do pentapeptídeo IIAEK, do pentapeptídeo IPAVF e/ou do hexapeptídeo IPAVFK e sais dos mesmos para a preparação de um inibidor de enzima de conversão de angiotensina.
BRPI0409521-9A 2003-05-05 2004-04-23 uso do pentapeptìdeo iiaek, do pentapeptìdeo ipavf e/ou do hexapeptìdeo ipavfk, produto alimentìcio e processo para a preparação de um produto alimentìcio BRPI0409521A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03076306 2003-05-05
PCT/EP2004/004386 WO2004098310A1 (en) 2003-05-05 2004-04-23 Peptides having an ace inhibiting effect

Publications (1)

Publication Number Publication Date
BRPI0409521A true BRPI0409521A (pt) 2006-04-18

Family

ID=33427135

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0409521-9A BRPI0409521A (pt) 2003-05-05 2004-04-23 uso do pentapeptìdeo iiaek, do pentapeptìdeo ipavf e/ou do hexapeptìdeo ipavfk, produto alimentìcio e processo para a preparação de um produto alimentìcio

Country Status (10)

Country Link
US (1) US20060216330A1 (pt)
EP (1) EP1619958A1 (pt)
JP (1) JP2006525260A (pt)
CN (1) CN1784146A (pt)
AU (1) AU2004237456B2 (pt)
BR (1) BRPI0409521A (pt)
CA (1) CA2523414A1 (pt)
MX (1) MXPA05011783A (pt)
WO (1) WO2004098310A1 (pt)
ZA (1) ZA200507881B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0612183A2 (pt) * 2005-04-28 2010-10-26 Unilever Nv metionina-alanina-prolina e/ou isoleucina-treonina-prolina ou seus sais, seus usos, métodos de tratamento, medicamento, suplemento alimentìcio, alimento, composições, processos de produção de isoleucina-treonina-prolina ou seu sal, de produção de metionina-alanina-prolina ou seu sal e de produção de metionina-alanina-prolina e/ou isoleucina-treonina-prolina
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
CN101618207B (zh) * 2009-06-17 2011-08-03 中国科学院大连化学物理研究所 多肽在制备ace抑制剂及降血压药物中的应用
CN101696233B (zh) * 2009-10-29 2012-02-01 吉林大学 蛋清蛋白血管紧张素转化酶抑制肽及其制备
CN102399262B (zh) * 2010-09-07 2013-09-18 任发政 具有血管紧张素转化酶抑制活性的三肽及其应用和组合物
CN102475884B (zh) * 2010-11-29 2013-08-14 中国科学院大连化学物理研究所 四个多肽在制备ace抑制剂及降血压药物中的应用
ES2394988B2 (es) * 2011-06-15 2013-06-06 Queizúar, S.L. Procedimiento optimizado para la obtención de péptidos inhibidores de la actividad de la eca a partir de suero lácteo, péptidos inhibidores de la eca y alimento que los comprende.
CN104558109B (zh) * 2013-10-21 2018-06-08 中国科学院大连化学物理研究所 源于油菜花粉的具有ace抑制活性的多肽化合物及应用
US12551526B2 (en) 2015-04-22 2026-02-17 Cedars-Sinai Medical Center Enterically delivered bitter oligopeptides for the treatment for type 2 diabetes
JP7291917B2 (ja) * 2020-03-13 2023-06-16 フォーデイズ株式会社 トリペプチドｒｐｒを含有する抗肥満薬並びに健康食品
CN113321719B (zh) * 2021-05-20 2022-03-18 澳优乳业（中国）有限公司 一种寡肽及其制备方法与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4205227B2 (ja) * 1999-01-11 2009-01-07 カルピス株式会社 ペプチド含有液の精製方法
EP1287159A4 (en) * 2000-05-08 2005-02-09 Davisco Foods Int Inc Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals

Also Published As

Publication number Publication date
AU2004237456B8 (en) 2007-10-04
ZA200507881B (en) 2006-12-27
WO2004098310A1 (en) 2004-11-18
EP1619958A1 (en) 2006-02-01
JP2006525260A (ja) 2006-11-09
AU2004237456B2 (en) 2007-10-04
MXPA05011783A (es) 2006-01-26
CN1784146A (zh) 2006-06-07
CA2523414A1 (en) 2004-11-18
AU2004237456A1 (en) 2004-11-18
US20060216330A1 (en) 2006-09-28

Similar Documents

Publication Publication Date Title
WO2008121742A3 (en) Inhibitors of bruton's tyrosine kinase
ES2619332T3 (es) Fosfatasa alcalina dirigida al hueso, kits y métodos de uso de la misma
BR0317715A (pt) Composições e processos de uso de collajolie
DE60007095T2 (de) Calanolide zur hemmung von btk
CA2245680A1 (en) Method of detection of influenza virus and compounds for use therein
WO2011046964A3 (en) Inhibitors of bruton's tyrosine kinase
AU2002314169A1 (en) Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
PT1171143E (pt) Extracto peptidico de tremoco e composicao farmaceutica ou cosmetica ou nutraceutica compreendendo o referido extracto
BR0207775A (pt) Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
SE0100901D0 (sv) New composition
MXPA05008519A (es) Forma de algodon mon 88913 y composiciones y metodos para detectarla.
BRPI0409521A (pt) uso do pentapeptìdeo iiaek, do pentapeptìdeo ipavf e/ou do hexapeptìdeo ipavfk, produto alimentìcio e processo para a preparação de um produto alimentìcio
UY27993A1 (es) Derivados de 4-pirrolidino-fenil-bencil eter
DE60233532D1 (de) An proteinphosphatase 2a bindende synthetische ode anwendungen
ATE345354T1 (de) Methode zur identifizierung von helicobacter antigenen
BR0109164A (pt) Anticorpos monoclonais para o receptor humano para ldl, produção e uso dos mesmos
WO2004043404A3 (en) Process for designing inhibitors of influenza virus non-structural protein 1
WO2003004517A3 (en) Peyers's patch and/or m-celle targeting ligands
EP1529837A3 (en) Microorganisms producing dipeptides and process for producing dipeptides using the microorganisms
ATE335745T1 (de) Verfahren zur herstellung von protease hemmenden zwischenprodukten
HUP0400262A2 (hu) Glikopeptidek, előállításuk és alkalmazásuk szklerózis multiplex kezelésében
WO2007056389A3 (en) Synthesis and use of novel inhibitors and inactivators of protein arginine deiminases
WO2001054707A3 (de) Veränderung von oberflächenproteomem durch aminopeptidase-inhibitoren
BRPI0416712A (pt) uso de tripeptìdeo xpp, produto alimentìcio e processo para a preparação de um produto alimentìcio
BR0111983A (pt) métodos e substratos de peptìdeo de metaloprotease

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.

B15K Others concerning applications: alteration of classification

Ipc: C07K 14/47 (2006.01), A23C 9/13 (2006.01), A23C 21